Efficacy and safety of anlotinib-based treatment in metastatic breast cancer patients
ObjectiveTo evaluate the efficacy and safety of anlotinib-based treatment in metastatic breast cancer (MBC) patients with failure of standard treatment.MethodsWe collected the medical data of 56 female patients with the diagnosis of MBC and had failed the standard treatment before. These patients re...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1042451/full |